Holen Sie sich die Stockscreener-App
10.97
0.05%
-0.00
Schlusskurs vom Vortag:
$10.97
Offen:
$10.88
24-Stunden-Volumen:
13,975
Relative Volume:
0.01
Marktkapitalisierung:
$486.65M
Einnahmen:
$78.02M
Nettoeinkommen (Verlust:
$-73.37M
KGV:
-6.5321
EPS:
-1.6794
Netto-Cashflow:
$-62.06M
1W Leistung:
-3.65%
1M Leistung:
-22.34%
6M Leistung:
-56.73%
1J Leistung:
-27.00%
1-Tages-Spanne:
$10.70
$10.97
1-Wochen-Bereich:
$10.05
$11.30
52-Wochen-Spanne:
$8.89
$32.71
Beta Bionics Inc Stock (BBNX) Company Profile
Firmenname
Beta Bionics Inc
Sektor
Branche
Telefon
949-427-7785
Adresse
11 HUGHES, IRVINE
Compare BBNX vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BBNX
Beta Bionics Inc
|
10.96 | 482.43M | 78.02M | -73.37M | -62.06M | -1.6794 |
|
ABT
Abbott Laboratories
|
109.98 | 192.10B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
356.32 | 137.25B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
89.70 | 115.41B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.78 | 103.81B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
85.33 | 49.82B | 6.07B | 1.06B | 1.34B | 1.8063 |
Beta Bionics Inc Stock (BBNX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-09 | Eingeleitet | UBS | Buy |
| 2026-01-27 | Eingeleitet | TD Cowen | Hold |
| 2026-01-09 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-10-21 | Fortgesetzt | Stifel | Buy |
| 2025-10-01 | Hochstufung | Goldman | Neutral → Buy |
| 2025-06-16 | Eingeleitet | Truist | Buy |
| 2025-06-12 | Eingeleitet | Lake Street | Buy |
| 2025-05-30 | Eingeleitet | Goldman | Neutral |
| 2025-05-30 | Eingeleitet | Wolfe Research | Outperform |
| 2025-02-24 | Eingeleitet | BofA Securities | Buy |
| 2025-02-24 | Eingeleitet | Lake Street | Buy |
| 2025-02-24 | Eingeleitet | Leerink Partners | Outperform |
| 2025-02-24 | Eingeleitet | Piper Sandler | Overweight |
| 2025-02-24 | Eingeleitet | Stifel | Buy |
| 2025-02-20 | Eingeleitet | Ladenburg Thalmann | Neutral |
| 2025-02-20 | Eingeleitet | Robert W. Baird | Neutral |
Alle ansehen
Beta Bionics Inc Aktie (BBNX) Neueste Nachrichten
Beta Bionics Earnings Call Signals Growth and Investment - TipRanks
INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics - TMX Newsfile
Will Beta Bionics Inc. stock deliver consistent dividends2025 Historical Comparison & Free Fast Entry Momentum Trade Alerts - Naître et grandir
Trade Recap: Why is Beta Bionics Inc stock going downWeekly Market Report & High Yield Equity Trading Tips - baoquankhu1.vn
BBNX INVESTOR NOTICE: Faruqi & Faruqi, LLP Launches Investigation into Beta Bionics - Bluefield Daily Telegraph
Beta Bionics Details iLet Automation Strategy, Sales Expansion and Mint Patch Pump Timeline at Conference - Yahoo Finance
INVESTIGATION NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics - Sahm
Beta Bionics, Inc. (NASDAQ:BBNX) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Insider Sell: Mark Hopman Sells Shares of Beta Bionics Inc (BBNX) - GuruFocus
Hopman, Beta Bionics CCO, sells $4k in BBNX stock By Investing.com - Investing.com Canada
Hopman, Beta Bionics CCO, sells $4k in BBNX stock - Investing.com UK
Beta Bionics, Inc. $BBNX Position Boosted by Pura Vida Investments LLC - MarketBeat
First Eagle Investment Management LLC Buys Shares of 233,202 Beta Bionics, Inc. $BBNX - MarketBeat
Aug Technicals: Can Beta Bionics Inc deliver alphaM&A Rumor & Long-Term Safe Investment Plans - baoquankhu1.vn
Stephen Feider files Form 144 to sell BBNX common stock (BBNX) - Stock Titan
Sean Saint to sell 3,384 Beta Bionics shares (BBNX) via Morgan Stanley - Stock Titan
Beta Bionics Receives Warning Letter from U.S. Department of Health and Human Services Food and Drug Administration Center - marketscreener.com
Medtronic Diabetes Unit MiniMed’s IPO Sparks Analyst Debate - Bloomberg.com
BBNX Earnings History & Surprises | EPS & Revenue Results | BETA BIONICS INC (NASDAQ:BBNX) - ChartMill
BBNX: iLet’s automation and Mint patch pump drive growth as pharmacy models reshape the market - TradingView
Beta Bionics Insider Sells $10,308 in Stock - National Today
Beta Bionics insider sells $13,151 in stock - National Today
BBNX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Beta Bionics Insiders Quietly Cash Out in a Wave of Executive Stock Sales - TipRanks
Beta Bionics (NASDAQ:BBNX) Insider Steven Jon Russell Sells 1,026 Shares - MarketBeat
Beta Bionics (NASDAQ:BBNX) CFO Sells $17,650.08 in Stock - MarketBeat
Mike Mensinger Sells 1,064 Shares of Beta Bionics (NASDAQ:BBNX) Stock - MarketBeat
Insider Selling: Beta Bionics (NASDAQ:BBNX) Insider Sells 834 Shares of Stock - MarketBeat
BBNX SEC FilingsBeta Bionics, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Beta Bionics (BBNX) CCO gets equity awards, sells shares for taxes - Stock Titan
Beta Bionics (BBNX) CMO sells shares, receives RSU and option awards - Stock Titan
BBNX CPO Mike Mensinger reports equity grants, tax-related sale in Form 4 - Stock Titan
[Form 4] Beta Bionics, Inc. Insider Trading Activity - Stock Titan
BBNX CEO Sean Saint gets major equity awards and small tax-related share sale - Stock Titan
BBNX SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors ... - Bluefield Daily Telegraph
BBNX SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics - Nasdaq
BBNX.O PE Ratio & Valuation, Is BBNX.O Overvalued - Intellectia AI
BBNX INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims o - GuruFocus
BBNX INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics - Financial Times
Beta Bionics, Inc. (BBNX) Stock Analysis: Exploring a Potential 79.85% Upside in Healthcare Innovation - DirectorsTalk Interviews
FDA warns Beta Bionics on unreported complaints, insulin pump changes - MedTech Dive
INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics - GlobeNewswire
Beta Bionics, Inc. ALERT: Securities Fraud Investigation by Block & Leviton Could Allow ... - Bluefield Daily Telegraph
Beta Bionics, Inc. ALERT: Securities Fraud Investigation by Block & Leviton Could Allow Investors to Recover Losses - GlobeNewswire
Beta Bionics Inc files for mixed shelf size not disclosedSEC filing - marketscreener.com
Beta Bionics Inc Files For Mixed Shelf Size Not DisclosedSEC Filing - TradingView
BBNX INVESTIGATION ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics - marketscreener.com
Point72 (NASDAQ: BBNX) holds 2.29M shares, a 5.2% stake in Beta Bionics - Stock Titan
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics - PR Newswire
Aug Swings: Is NYMTM currently under institutional pressureWeekly Profit Recap & Expert Approved Momentum Ideas - baoquankhu1.vn
RTW INVESTMENTS, LP Reduces Stake in Beta Bionics Inc - GuruFocus
Finanzdaten der Beta Bionics Inc-Aktie (BBNX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.23%
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):